We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BECN
1001
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $1.2M | ﹤0.01% |
9,731
+952
| +11% | +$111K |
|
1002
Evercore
EVR
$11.5B
| $1.2M | ﹤0.01% |
5,988
+508
| +9% | +$127K |
|
1003
MasTec
MTZ
$22.6B
| $1.2M | ﹤0.01% |
10,251
+301
| +3% | +$40.6K |
|
1004
Western Alliance Bancorporation
WAL
$9.01B
| $1.2M | ﹤0.01% |
15,562
+1,451
| +10% | +$122K |
|
1005
Jefferies Financial Group
JEF
$12.6B
| $1.19M | ﹤0.01% |
22,202
+266
| +1% | +$18.1K |
|
1006
National Fuel Gas
NFG
$7.77B
| $1.16M | ﹤0.01% |
14,701
+491
| +3% | +$35.3K |
|
1007
CAVA Group
CAVA
$8.11B
| $1.16M | ﹤0.01% |
13,414
+2,142
| +19% | +$232K |
|
1008
ATI
ATI
$31.4B
| $1.16M | ﹤0.01% |
22,280
+3,040
| +16% | +$173K |
|
1009
EXL Service
EXLS
$5.2B
| $1.15M | ﹤0.01% |
24,398
+687
| +3% | +$33.1K |
|
1010
Crane Co
CR
$12.9B
| $1.15M | ﹤0.01% |
7,511
+491
| +7% | +$78.8K |
|
|
WCC
1011
WESCO International
WCC
$17.8B
| $1.15M | ﹤0.01% |
7,384
+1,153
| +19% | +$206K |
|
1012
Eagle Materials
EXP
$6.47B
| $1.15M | ﹤0.01% |
5,160
-5,449
| -51% | -$1.29M |
|
1013
Cullen/Frost Bankers
CFR
$10.4B
| $1.14M | ﹤0.01% |
9,138
+233
| +3% | +$31.3K |
|
1014
Cousins Properties
CUZ
$4.85B
| $1.14M | ﹤0.01% |
38,699
-14,002
| -27% | -$419K |
|
1015
Procore
PCOR
$8.81B
| $1.14M | ﹤0.01% |
17,184
-381
| -2% | -$28.7K |
|
|
MASI
1016
DELISTED
Masimo
MASI
| $1.13M | ﹤0.01% |
6,791
+399
| +6% | +$69.2K |
|
1017
Commerce Bancshares
CBSH
$8.56B
| $1.13M | ﹤0.01% |
19,018
+565
| +3% | +$34.4K |
|
1018
Bath & Body Works
BBWI
$3.65B
| $1.12M | ﹤0.01% |
36,958
+4,454
| +14% | +$158K |
|
1019
Option Care Health
OPCH
$3.57B
| $1.12M | ﹤0.01% |
32,013
-872
| -3% | -$27.4K |
|
1020
UMB Financial
UMBF
$11.4B
| $1.11M | ﹤0.01% |
11,027
+4,236
| +62% | +$467K |
|
1021
Caesars Entertainment
CZR
$6.04B
| $1.11M | ﹤0.01% |
44,577
+1,493
| +3% | +$48.6K |
|
1022
Regal Rexnord
RRX
$11.5B
| $1.11M | ﹤0.01% |
9,775
+452
| +5% | +$62.8K |
|
1023
Teleflex
TFX
$5.78B
| $1.11M | ﹤0.01% |
8,036
-23,991
| -75% | -$3.89M |
|
1024
Intercorp Financial Services
IFS
$6.06B
| $1.11M | ﹤0.01% |
33,500
-1,000
| -3% | -$31.4K |
|
1025
Fabrinet
FN
$20.5B
| $1.11M | ﹤0.01% |
5,617
+675
| +14% | +$147K |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.